PI: Gregory Albers, MD (NCT01794182) Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial A phase III study to determine if aspirin and clopidogrel together reduces the risk of stroke, heart attacks and other complications compared to aspirin alone.